Why is Welcure Drugs falling/rising?

As of 15-Oct, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 8.13, which reflects a decrease of 0.32 or 3.79%. The stock has underperformed its sector by 3.87% today and has seen a trend reversal after nine consecutive days of gains. While the stock's performance over the past week shows a significant increase of 16.64%, it has declined by 3.10% over the past month and is down 30.33% year-to-date. The stock's moving averages indicate that it is currently higher than the 5-day and 20-day averages but lower than the 50-day, 100-day, and 200-day moving averages. Additionally, there has been a rise in investor participation, with a delivery volume of 18.75 lacs on 14 October, which is 1.64% higher than the 5-day average.
In the broader market context, the Sensex has shown a modest increase of 1.02% over the past week and 1.00% over the past month, contrasting with Welcure Drugs' recent performance. The stock's year-to-date decline of 30.33% starkly contrasts with the Sensex's gain of 5.72% in the same period, highlighting a significant underperformance relative to the benchmark. This disparity suggests that while the stock has had a brief period of recovery, it remains vulnerable to broader market trends and investor sentiment, which may be affecting its current price movement.